For the past 17 years, the Cleveland Clinic has predicted what the top 10 medical disruptors will be for the following year. The list of technologies, cultivated by a panel of physicians and scientists at the clinic, was led by Dr. Michael Roizen, emeritus chief wellness officer. “Healthcare is ever-changing and we anticipate that these […]
DeviceTalks Q&A: Talking targeted pain management with CEO Maria Bennett
At DeviceTalks Minnesota 2019, SPR Therapeutics founder, president & CEO Maria Bennett spoke with DeviceTalks program manager Sarah Faulkner about the company’s FDA-cleared peripheral nerve stimulation system for pain management. Want to see these interviews live? Join us at DeviceTalks West – Dec. 9-10 in Santa Clara, Calif. Sarah: Could you tell us a little […]
Report: Medtronic establishes $35m settlement fund for Synchromed pumps
Medtronic (NYSE:MDT) last week reportedly agreed to create a settlement fund worth some $35 million to compensate those who say they were harmed by the SynchroMed II intrathecal drug pump. The settlement involves about 500 people who claimed harm came from use of the pain-fighting pump, represented by three law firms that are negotiating individual […]
FDA approves Abbott’s recharge-free spinal cord stimulator
Abbott (NYSE:ABT) announced today that the FDA has approved its low-dose, recharge-free spinal cord stimulation system with up to 10-year battery life for people in chronic pain. The Proclaim XR neurostimulation system couples low-energy therapy with a low-dosing protocol to provide pain relief and preserve its battery. Abbott said its BurstDR stimulation waveform was designed to […]
ElectroCore plunges after FDA asks for more GammaCore data
ElectroCore (NSDQ:ECOR) shares plunged today after the company said the FDA asked for more data on a bid for an expanded indication for its GammaCore device. Basking Ridge, N.J.-based ElectroCore asked for an expanded 510(k) indication covering prevention of migraine with ElectroCore, a non-invasive vagus nerve stimulator. Today the company said the federal safety watchdog asked […]
Stimwave appeals injunction in Nevro patent war
Stimwave yesterday appealed a preliminary injunction barring it from using higher-frequency neurostim to treat chronic pain in a patent spat with rival Nevro (NYSE:NVRO). Redwood City, Calif.-based Nevro brought the suit in February, alleging that Stimwave infringed on patents related to Nevro’s Senza system and HF10 therapy. The lawsuit, filed in the U.S. District Court for Delaware, […]
MedTech Innovator announces five finalists in competition
MedTech Innovator last week announced the five finalists for its $500,000 competition. The organization will award more than $500,000 in prizes to the finalists with first place taking $350,000 and the four remaining finalists taking $25,000. Five finalists will have seven minutes to pitch their technologies to a panel of four judges. The audience will […]
Former NFL player may pursue pain pump lawsuit against Stryker, I-Flow
A former NFL player may proceed with a federal lawsuit against Stryker (NYSE:SYK) and I-Flow over a pain pump that the player claims destroyed the cartilage in his shoulder. U.S. District Court Judge Gloria Navarro ruled last week that former New England Patriots linebacker Ryan Claridge could add specifics to his claim that Stryker and […]
Flowonix warns on software anomaly with Prometra pump
Flowonix earlier this month warned about a software anomaly with its Prometra infusion pump that could unexpectedly shut down the device. The Budd Lake, N.J.-based company won FDA approval in February for updated software included in the Prometra system, which is indicated for intrathecal infusion of drug therapy, including infumorph, saline and baclofen. Flowonix warned […]
Nevro beats the Street with Q2 results
Shares in Nevro (NYSE:NVRO) rose this week after the medical device maker topped expectations on Wall Street with its second-quarter financial results. The Redwood City, Calif.-based company posted a net loss of -$28 million on sales of $93.6 million for the three months ended June 30. Compared with the same period last year, Nevro’s revenue fell […]
Ocular Therapeutix’s ophthalmic device gains Medicare coverage early
Ocular Therapeutix (NSDQ:OCUL) said today that the Centers for Medicare and Medicaid Services has assigned a specific and permanent reimbursement J-code for its Dextenza ophthalmic insert, which is approved for the treatment of ocular inflammation and pain following ophthalmic surgery. The code assigned to Dextenza through the Healthcare Common Procedure Coding System will become effective on […]
- 1
- 2
- 3
- …
- 33
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube